Angle (AGL) RNS Announcements

Add to Alert list
Date Time Source Announcement
30 Oct 2019 07:00 AM
RNS
Q-submission to FDA containing headline data
08 Oct 2019 07:00 AM
RNS
Notice of AGM
04 Oct 2019 05:54 PM
RNS
Holding(s) in Company
04 Oct 2019 07:00 AM
RNS
European patent granted for megakaryocyte analysis
13 Sep 2019 07:00 AM
RNS
Use of Parsortix in head and neck cancer
10 Sep 2019 07:00 AM
RNS
Research with Parsortix in prostate cancer
04 Sep 2019 07:00 AM
RNS
Parsortix for Neuroendocrine Analysis in SCLC
29 Aug 2019 07:00 AM
RNS
Initiation of Ovarian Cancer Study
31 Jul 2019 07:00 AM
RNS
Prelim Results for the year ended 30 April 2019
22 Jul 2019 07:00 AM
RNS
Use of Parsortix for single cell analysis of CTCs
16 Jul 2019 09:19 AM
RNS
Holding(s) in Company
12 Jul 2019 10:22 AM
RNS
Result of General Meeting anf Total Voting Rights
28 Jun 2019 01:37 PM
RNS
Notice of Preliminary Results and Webcast
28 Jun 2019 01:08 PM
RNS
Holding(s) in Company
25 Jun 2019 05:19 PM
RNS
Result of Placing
25 Jun 2019 08:02 AM
RNS
Accelerated bookbuild to raise £18.0m
21 Jun 2019 07:00 AM
RNS
Parsortix used to investigate immunotherapy target
05 Jun 2019 07:00 AM
RNS
Completion of Ovarian Cancer Pre-Study
31 May 2019 07:00 AM
RNS
Positive Results from FDA Clinical Study
26 Apr 2019 07:00 AM
RNS
IMMUNE SUPPRESSOR CELLS PROMOTE METASTASIS
18 Apr 2019 07:00 AM
RNS
Parsortix used in new cancer assessment technique
12 Apr 2019 07:00 AM
RNS
LUNG CANCER STUDY USES ANGLE'S PARSORTIX SYSTEM
04 Apr 2019 07:00 AM
RNS
AACR 2019
11 Mar 2019 07:00 AM
RNS
Holding(s) in Company
07 Mar 2019 07:00 AM
RNS
ENROLMENT COMPLETE FOR FDA CLINICAL STUDY
28 Feb 2019 07:00 AM
RNS
FIRST SUBJECTS ENROLLED IN OVARIAN CANCER STUDY
25 Feb 2019 07:00 AM
RNS
CUSTOMER DEMONSTRATES NEW USE FOR PARSORTIX
11 Feb 2019 07:00 AM
RNS
Research into role of immune cells in cancer
31 Jan 2019 07:00 AM
RNS
Interim Results
29 Jan 2019 07:00 AM
RNS
NEW APPLICATION FOR PARSORTIX IN CANCER ANALYSIS
11 Jan 2019 02:05 PM
RNS
Second Price Monitoring Extn
11 Jan 2019 02:00 PM
RNS
Price Monitoring Extension
11 Jan 2019 11:05 AM
RNS
Second Price Monitoring Extn
11 Jan 2019 11:00 AM
RNS
Price Monitoring Extension
11 Jan 2019 09:05 AM
RNS
Second Price Monitoring Extn
11 Jan 2019 09:00 AM
RNS
Price Monitoring Extension
10 Jan 2019 04:41 PM
RNS
Second Price Monitoring Extn
10 Jan 2019 04:36 PM
RNS
Price Monitoring Extension
10 Jan 2019 04:01 PM
RNS
BREAKTHROUGH CANCER RESEARCH USING PARSORTIX
09 Jan 2019 07:00 AM
RNS
Notice of Results
21 Dec 2018 07:00 AM
RNS
Issue of LTIP Options and Share Options
28 Nov 2018 07:00 AM
RNS
LEADING US HEMATOPATHOLOGIST APPOINTED AS ADVISOR
13 Nov 2018 05:10 PM
RNS
Holding(s) in Company
05 Nov 2018 07:00 AM
RNS
Acquisition of outstanding shares
02 Nov 2018 02:00 PM
RNS
Price Monitoring Extension
01 Nov 2018 07:00 AM
RNS
Appointment of Dr Jan Groen as NED
30 Oct 2018 04:21 PM
RNS
Result of AGM
29 Oct 2018 07:00 AM
RNS
PARSORTIX SHOWS CAPABILITY TO HARVEST FETAL CELLS
25 Oct 2018 07:00 AM
RNS
Good Progress with FDA Studies
09 Oct 2018 07:00 AM
RNS
Notice of AGM
UK 100

Latest directors dealings